The FDA’s label expansion came after Tandem and Dexcom published a study earlier this year focusing specifically on toddlers’ use of their combined automated insulin delivery system. The study ...

Tandem Diabetes Care has entered into distribution agreements to commercialize its t:slim X2™ Insulin Pump in Australia and New Zealand.

Tandem Diabetes Care Inc, a leading provider in the realm of insulin delivery and diabetes technology, is revolutionizing diabetes management with its cutting-edge solutions.

Tandem Diabetes Care enters into distribution agreement with Rubin Medical to commercialize insulin pump products in Sweden, Norway and Denmark.

Tandem Diabetes Care specializes in diabetes management products, most notably insulin pumps for T1D patients. See why I still rate TNDM stock as a buy.

Tandem Diabetes Care Inc, a leading provider in the realm of insulin delivery and diabetes technology, is revolutionizing diabetes management with its cutting-edge solutions. Known for its ...

Tandem Diabetes delivered weaker-than-expected Q4 results but followed with strong forward guidance. The company launched four new products in the U.S. last quarter. For its fourth quarter of 2023 ...

The FDA is alerting users and providers to Tandem Diabetes Care’s recall of its insulin pump-controlling iPhone app after a software bug was found to quickly drain the pump’s battery ...

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today announced the appointment of Elizabeth Gasser as its new Executive Vice President, Strategy and ...